RxSight (RXST) Profit After Tax (2020 - 2026)
RxSight's (RXST) quarterly Profit After Tax came in at -$16.0 million in Q1 2026, down 91.87% YoY from -$196.9 million in Q1 2025, and up 58.79% on a QoQ basis from -$38.8 million in Q4 2025.
RxSight (RXST) Profit After Tax (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Profit After Tax data on file, last reported at -$16.0 million in Q1 2026.
- Quarterly Profit After Tax fell 91.87% year-over-year to -$16.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76.4 million (down 186.35% YoY) and the FY2025 annual result came in at -$38.9 million, down 41.85% from the prior year.
- Profit After Tax climbed to -$16.0 million in Q1 2026, from -$38.8 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$5.9 million in Q4 2024 to a low of -$38.8 million in Q4 2025.
- A 5-year average of -$13.4 million and a median of -$12.4 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax soared 67.93% — and 2025, when it sank 554.08%.
- Tracing RXST's Profit After Tax over 5 years: stood at -$15.6 million in 2022, then soared by 41.79% to -$9.1 million in 2023, then surged by 34.65% to -$5.9 million in 2024, then slumped by 554.08% to -$38.8 million in 2025, then surged by 58.79% to -$16.0 million in 2026.
- The last three Profit After Tax figures came in at -$16.0 million (Q1 2026), -$38.8 million (Q4 2025), and -$9.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | RxSight | 250.81 Mn | -153.43 Mn | - | -12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.10 Mn |
| Mar 31, 2026 | -16.00 Mn |
| Dec 31, 2025 | -38.84 Mn |
| Sep 30, 2025 | -9.82 Mn |
| Jun 30, 2025 | -11.79 Mn |
| Mar 31, 2025 | -8.34 Mn |
| Dec 31, 2024 | -5.94 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -6.08 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -9.09 Mn |
| Sep 30, 2023 | -12.40 Mn |
| Jun 30, 2023 | -13.80 Mn |
| Mar 31, 2023 | -13.21 Mn |
| Dec 31, 2022 | -15.61 Mn |
| Sep 30, 2022 | -16.77 Mn |
| Jun 30, 2022 | -16.73 Mn |
| Mar 31, 2022 | -17.60 Mn |
| Dec 31, 2021 | -48.68 Mn |
| Sep 30, 2021 | -12.67 Mn |